|
|
Effect of local infusion of budesonide combined with acetylcysteine in treatment of severe pneumonia in children after bronchoalveolar lavage |
LIU Ruihua, TIAN Chen, YAN Yan, ZHANG Jingjing |
Department of Pediatrics, Characteristics Medical Center of Chinese People's Armed Police Force, Tianjin 300162, China |
|
|
Abstract Objective To investigate the effect of local perfusion of budesonide combined with acetylcysteine in the treatment of severe pneumonia in children after electronic bronchoscopic alveolar lavage (BAL). Methods A total of 74 children with severe pneumonia admitted to the Pediatric Department of Characteristics Medical Center of Chinese People's Armed Police Force from September 2023 to August 2024 were selected and divided into an observation group (n=37) and a control group (n=37). On the basis of conventional treatment, the control group was treated with 0.9% NaCl alveolar lavage using electronic bronchoscopy, while the observation group was treated with local infusion of budesonide combined with acetylcysteine in addition to the control group. The clinical efficacy, cough disappearance time, body temperature recovery time, inflammatory indicators, hospitalization time, and incidence of adverse reactions were observed respectively in the two groups. Results The clinical efficacy, inflammatory indicators, and hospitalization stay of the observation group were significantly better than those of the control group, with statistically significant difference (P<0.05). There was no statistically significant difference in the recovery time of body temperature, disappearance time of cough, and incidence of adverse reactions between the two groups. Conclusions Local infusion of budesonide combined with acetylcysteine after alveolar lavage is characterized by significant clinical effect in the treatment of children with severe pneumonia, which can accelerate the absorption of pulmonary inflammatory lesions, shorten the length of hospital stay and reduce inflammatory indicators.
|
Received: 10 September 2024
|
|
|
|
|
[1] |
罗 乐,黎 松,张佩雯,等.盐酸氨溴索联合利奈唑胺治疗重症肺炎对血气指标及血清TNF-α、HMGB1的影响[J].西部医学,2021,33(7):1044-1047.
|
[2] |
陈俊先,林民豪,吴桂清,等.乙酰半胱氨酸、布地奈德、纤维支气管镜下肺泡灌洗三者联合治疗重症肺炎的应用研究[J].中国医药科学,2023,13(16):17-20.
|
[3] |
中华医学会儿科学分会呼吸学组,《中华儿科杂志》编辑委员会.儿童社区获得性肺炎管理指南(2013修订)(下)[J].中华儿科杂志,2013,51(10):745-752.
|
[4] |
国家卫生健康委员会人才交流服务中心儿科呼吸内镜诊疗技术专家组,等.中国儿科可弯曲支气管镜技术指南(2018年版)[J].中华实用儿科临床杂志,2018,33(13):983-989.
|
[5] |
杨 阳.乙酰半胱氨酸肺泡灌洗联合布地奈德治疗儿童重症肺炎支原体肺炎疗效观察[J].内蒙古医学杂志,2023,55(1):28-30.
|
[6] |
宋 超,李 涛,王 妍,等.纤维支气管镜肺泡灌洗联合乙酰半胱氨酸局部注入治疗重症肺炎的效果及安全性[J].临床误诊误治,2021,34(6):80-85.
|
[7] |
王永军,王文媛,易 彬,等.中国儿童支气管肺泡灌洗术临床实践指南(2024)[J].中国当代儿科杂志,2024,26(1):1-13.
|
[8] |
Wallihan R,Ramilo O.Community-acquired pneumonia in children: current challenges and future directions[J].J Infect, 2014,69:S87-S90.
|
[9] |
陶 珊,刘秀平,卓志强.儿童重症肺炎病原学调查及病原菌耐药性分析[J].中国现代医师,2020,58(33):21-24.
|
[10] |
陈德晖,黄 燕,焦安夏,等.中国儿童难治性肺炎呼吸内镜介入诊疗专家共识[J].中国实用儿科杂志,2019,34(6):449-457.
|
[11] |
姚四一,吕雪彩,王苗苗,等.盐酸右美托咪定滴鼻应用于老年患者纤维支气管镜检查的效果[J].武警医学,2022,33(5):408-411,415.
|
[12] |
中华医学会呼吸病学分会.雾化祛痰临床应用的中国专家共识[J].中华结核和呼吸杂志,2021,44(4):340-348.
|
[13] |
卢 薇,向 龙,付 华,等.支气管镜肺泡灌洗辅助治疗对小儿重症支原体肺炎临床效果、炎性因子及肺功能的影响[J].临床误诊误治,2022,35(2):87-91.
|
[14] |
王 维,罗永姣.乙酰半胱氨酸联合布地奈德雾化吸入治疗儿童肺炎疗效观察[J].海南医学,2019,30(24):3213-3216.
|
[15] |
曹 芳,方识进,华 山,等.电子纤维支气管镜保留灌注乙酰半胱氨酸及布地奈德治疗儿童难治性支原体肺炎的临床效果观察[J].中国医药,2020,15(3):369-373.
|
[16] |
Mokra D,Drgova A,Petras M,et al.N-acetylcysteine alleviates the meconium-induced acute lung injury[J].Adv Exp Med Biol, 2015,832:59-67.
|
[17] |
王吉胜,吴立存,吴 慧,等.雾化吸入乙酰半胱氨酸联合布地奈德治疗婴幼儿肺炎临床疗效观察[J].中华全科医学,2021,19(9):1518-1521.
|
[18] |
边宁宁.探讨纤维支气管镜支气管肺泡灌洗术治疗重症肺部感染的有效性[J].中国现代药物应用,2024,18(17):35-38.
|
[19] |
吴倩倩,彭 斌,郑庆峰.探讨应用布地奈德联合纤维支气管镜肺泡灌洗治疗小儿难治性肺炎支原体肺炎的效果[J].中外医疗,2024,43(20):92-95.
|
|
|
|